99 related articles for article (PubMed ID: 2051776)
1. Prostacyclin production in the area of arterial endothelial denudation.
Schwarcz TH; Eton D; Ellenby MI; Dieter J; Dy J; Tessalee M; Shrader D; LeBreton GC
J Surg Res; 1991 Jun; 50(6):638-42. PubMed ID: 2051776
[TBL] [Abstract][Full Text] [Related]
2. The association of in vitro arachidonic acid responsiveness and plasma thromboxane levels with early platelet deposition on the luminal surface of small-diameter grafts.
Freeman MB; Sicard GA; Valentin LI; Neuberger S; Mangino MJ; Anderson CB
J Vasc Surg; 1988 Apr; 7(4):554-61. PubMed ID: 3127601
[TBL] [Abstract][Full Text] [Related]
3. Thromboxane A2 and prostacyclin generation in the microvasculature of patients with atherosclerosis--effect of low-dose aspirin.
Kyrle PA; Minar E; Brenner B; Eichler HG; Heistinger M; Marosi L; Lechner K
Thromb Haemost; 1989 Jun; 61(3):374-7. PubMed ID: 2508252
[TBL] [Abstract][Full Text] [Related]
4. Incomplete biochemical adaptation of vein grafts to the arterial environment in terms of prostacyclin production.
Cahill PD; Brown BA; Handen CE; Kosek JC; Miller DC
J Vasc Surg; 1987 Nov; 6(5):496-503. PubMed ID: 3312650
[TBL] [Abstract][Full Text] [Related]
5. Prostacyclin production in regions of arterial stenosis.
Qvarfordt PG; Reilly LM; Lusby RJ; Effeney DJ; Ferrell LD; Price DC; Fuller J; Ehrenfeld WK; Stoney RJ; Goldstone J
Surgery; 1985 Sep; 98(3):484-91. PubMed ID: 3898454
[TBL] [Abstract][Full Text] [Related]
6. Effect of vacuum curettage on the concentrations of plasma 6-keto-prostaglandin F1 alpha and serum thromboxane B2.
Ylikorkala O; Mäkilä UM; Viinikka L
Br J Obstet Gynaecol; 1983 Mar; 90(3):251-4. PubMed ID: 6338904
[TBL] [Abstract][Full Text] [Related]
7. Prostacyclin and thromboxane production by autogenous femoral veins grafted into the arterial circulation of the dog.
de Castellarnau C; Cullare C; Lopez S; Bonnin O; Montesinos A; Guix M; Rutllant ML
Thromb Haemost; 1989 Apr; 61(2):279-85. PubMed ID: 2665174
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of the antiaggregatory activity of prostacyclin by propranolol in human platelets.
Callahan KS; Johnson AR; Campbell WB
Circulation; 1985 Jun; 71(6):1237-46. PubMed ID: 2986877
[TBL] [Abstract][Full Text] [Related]
9. Aspirin-induced decline in prostacyclin production in patients with coronary artery disease is due to decreased endoperoxide shift. Analysis of the effects of a combination of aspirin and n-3 fatty acids on the eicosanoid profile.
Force T; Milani R; Hibberd P; Lorenz R; Uedelhoven W; Leaf A; Weber P
Circulation; 1991 Dec; 84(6):2286-93. PubMed ID: 1959184
[TBL] [Abstract][Full Text] [Related]
10. Unidirectional transfer of prostaglandin endoperoxides between platelets and endothelial cells.
Schafer AI; Crawford DD; Gimbrone MA
J Clin Invest; 1984 Apr; 73(4):1105-12. PubMed ID: 6423665
[TBL] [Abstract][Full Text] [Related]
11. Prostanoid synthesis by aortic rings in human blood: selective increase of prostacyclin mediated by a serum factor.
Ritter JM
Br J Pharmacol; 1984 Oct; 83(2):409-18. PubMed ID: 6386089
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin production and platelet reactivity of small-diameter grafts.
Sicard GA; Allen BT; Long JA; Welch MJ; Griffin A; Clark RE; Anderson CB
J Vasc Surg; 1984 Nov; 1(6):774-81. PubMed ID: 6238179
[TBL] [Abstract][Full Text] [Related]
13. Combined arachidonic acid and ADP platelet inhibition maximizes patency of small-diameter vascular grafts.
Valentin LI; Sicard GA; Freeman MB; Allen BT; McGoff MA; Anderson CB
Surgery; 1988 Aug; 104(2):178-84. PubMed ID: 3135624
[TBL] [Abstract][Full Text] [Related]
14. Vascular prostaglandin and thromboxane production in a canine model of myocardial ischemia.
Schmitz JM; Apprill PG; Buja LM; Willerson JT; Campbell WB
Circ Res; 1985 Aug; 57(2):223-31. PubMed ID: 3926340
[TBL] [Abstract][Full Text] [Related]
15. Arterial wall rather than platelets is responsible for diminished thrombogenicity during isradipine therapy.
Sinzinger H; Keiler A; O'Grady J
J Cardiovasc Pharmacol; 1995 Mar; 25(3):453-8. PubMed ID: 7769812
[TBL] [Abstract][Full Text] [Related]
16. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
[TBL] [Abstract][Full Text] [Related]
17. Prostacyclin production by arterialized autogenous venous grafts in dogs.
Eldor A; Hoover EL; Pett SB; Gay WA; Alonso DR; Weksler BB
Prostaglandins; 1981 Sep; 22(3):485-98. PubMed ID: 6795687
[TBL] [Abstract][Full Text] [Related]
18. Effects of aspirin dosage and time of administration on arterial prostacyclin production and platelet aggregation in rats.
Philp RB; Paul ML
Prostaglandins Leukot Med; 1984 Jul; 15(1):91-102. PubMed ID: 6382343
[TBL] [Abstract][Full Text] [Related]
19. Augmented thromboxane generation by mesenteric arteries from pancreatectomized diabetic dogs is coincident with the vascular tone enhancement evoked by Na arachidonate and prostacyclin.
Sterin-Borda L; Franchi AM; Borda ES; Del Castillo E; Gimeno MF; Gimeno AL
Eur J Pharmacol; 1984 Aug; 103(3-4):211-21. PubMed ID: 6436040
[TBL] [Abstract][Full Text] [Related]
20. The effects of prostacyclin (PGI2) on endotoxin shock and endotoxin-induced platelet aggregation in dogs.
Fletcher JR; Ramwell PW
Circ Shock; 1980; 7(3):299-308. PubMed ID: 7004660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]